Palma Elisa, Carvalho Josué, Cruz Carla, Paulo António
C2TN-Centro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Estrada Nacional 10, 2695-066 Bobadela LRS, Portugal.
CICS-UBI-Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Av. Infante D. Henrique, 6200-506 Covilhã, Portugal.
Pharmaceuticals (Basel). 2021 Jun 23;14(7):605. doi: 10.3390/ph14070605.
The ability of fluorescent small molecules, such as metal complexes, to selectively recognize G-quadruplex (G4) structures has opened a route to develop new probes for the visualization of these DNA structures in cells. The main goal of this review is to update the most recent research efforts towards the development of novel cancer theranostic agents using this type of metal-based probes that specifically recognize G4 structures. This encompassed a comprehensive overview of the most significant progress in the field, namely based on complexes with Cu, Pt, and Ru that are among the most studied metals to obtain this class of molecules. It is also discussed the potential interest of obtaining G4-binders with medical radiometals (e.g., Tc, In, Cu, Pt) suitable for diagnostic and/or therapeutic applications within nuclear medicine modalities, in order to enable their theranostic potential.
荧光小分子(如金属配合物)选择性识别G-四链体(G4)结构的能力,为开发用于可视化细胞中这些DNA结构的新探针开辟了一条途径。本综述的主要目的是更新利用这类特异性识别G4结构的金属基探针开发新型癌症诊疗试剂的最新研究成果。这包括对该领域最重要进展的全面概述,即基于与铜、铂和钌形成的配合物,这些金属是研究最多的用于获得这类分子的金属。还讨论了获得适用于核医学诊断和/或治疗应用的医用放射性金属(如锝、铟、铜、铂)的G4结合剂的潜在意义,以实现其诊疗潜力。